Asbestos Research Today is a free monthly online journal that collates and summarizes the latest research about Asbestos, including details on mesothelioma, lung disease, dangers, effects, risks.

Volume 3 (2006), Issue 3 (March)

1. Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.
   Biochem Biophys Res Commun, 342(4): 1228-32. [Abstract] [Full-text]
2. Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite.
   J Natl Cancer Inst, 98(6): 414-7. [Abstract] [Full-text]
3. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
   J Clin Oncol, 24(9): 1443-8. [Abstract] [Full-text]
4. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.
   J Clin Oncol, 24(9): 1435-42. [Abstract] [Full-text]
5. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
   J Clin Oncol, 24(10): 1561-7. [Abstract] [Full-text]

© 2004-2008 Asbestos Research Today. All Rights Reserved.